Screening compound: C25H33N3O3 (T655-0269)

Screening compound: C<sub>25</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub> (T655-0269)
Screening compound: C<sub>25</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub> (T655-0269) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C25H33N3O3 (T655-0269)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T655-0269

Molecular Formula

C25H33N3O3 (C25 H33 N3 O3)

Compound Name

2-cyclohexyl-1-{4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decan-2-yl}ethan-1-one

IUPAC name

2-cyclohexyl-1-{4-[5-(4-methylphenyl)-134-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decan-2-yl}ethan-1-one

SMILES

Cc(cc1)ccc1-c1nnc(C(CN(C2)C(CC3CCCCC3)=O)C22CCOCC2)o1

InChI

InChI=1S/C25H33N3O3/c1-18-7-9-20(10-8-18)23-26-27-24(31-23)21-16-28(17-25(21)11-13-30-14-12-25)22(29)15-19-5-3-2-4-6-19/h7-10,19,21H,2-6,11-17H2,1H3/t21-/m0/s1

InChI Key

WDCCKKMUEVGNJT-NRFANRHFSA-N

MDL Number (MFCD)

MFCD29002640

C25H33N3O3 (T655-0269) in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Peptidomimetic Library (37031 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with C25H33N3O3 (T655-0269) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C25H33N3O3 (T655-0269)?
Check Price and Availability of C25H33N3O3 (T655-0269), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C25H33N3O3 (T655-0269) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C25H33N3O3 (T655-0269)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C25H33N3O3 (T655-0269)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C25H33N3O3 (T655-0269) available by request